New EU Approvals

The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include two new products, one of which is Vyjuvek, Krystal Biotech's advanced therapy for treating dystrophic epidermolysis bullosa.

New EU Approvals
(Shutterstock/Pink Sheet) • Source: Shutterstock (Pixelvario)

More from Approvals

More from Geography